profound: olaparib for hrr mcrpc
Published 4 years ago • 430 plays • Length 4:30Download video MP4
Download video MP3
Similar videos
-
9:59
profound performance: olaparib vs. enzalutamide or abiraterone for hrr altered mcrpc
-
10:21
profound: olaparib vs enzalutamide or abiraterone for mcrpc with hrr gene alterations
-
1:30
dr. agarwal on the safety profile of olaparib in hrr gene-mutant mcrpc
-
38:45
the profound trial - lynparza in hrrm mcrpc
-
2:40
researcher comment: profound improvement in outcomes with olaparib in mcrpc | maha hussain
-
1:40
dr. maughan discusses abiraterone plus olaparib in mcrpc
-
1:15
brcaaway: abiraterone with olaparib in mcrpc with hrr mutations
-
1:32
dr. hussain on results of the profound trial in mcrpc
-
1:45
the propel clinical trial exploring olaparib plus abiraterone in mcrpc
-
4:21
phase ii results of olaparib and abiraterone for mcrpc
-
1:14
dr. yu on combining pembrolizumab and olaparib in mcrpc
-
16:07
profound trial shows increased rpfs in mcrpc patients with brca1, brca2, and atm mutations
-
3:05
mcrpc: the importance of genomic profiling
-
1:18
dr. hussain on the clinical impact of the profound trial in mcrpc
-
9:15
fda approval of lynparza® in us for hrr gene-mutated mcrpc
-
5:15
rucaparib and olaparib: two new treatments approved for advanced prostate cancer | pcri
-
1:38
dr. morgan on olaparib for metastatic castration-resistant prostate cancer
-
4:08
propel: final os of first-line abiraterone plus olaparib for mcrpc
-
1:37
olaparib plus abiraterone for mcrpc: are biomarkers necessary?